Nifty
Sensex
:
:
24800.85
81343.46
187.85 (0.76%)
626.91 (0.78%)

Pharmaceuticals & Drugs

Rating :
56/99

BSE: 524774 | NSE: NGLFINE

2466.85
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  2401.00
  •  2499.00
  •  2400.65
  •  2400.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  9112
  •  223.77
  •  2823.90
  •  1728.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,615.24
  • 39.09
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,645.97
  • 0.07%
  • 6.15

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.74%
  • 1.84%
  • 21.82%
  • FII
  • DII
  • Others
  • 0.03%
  • 0.00%
  • 3.57%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.31
  • 12.67
  • 2.53

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.82
  • 1.60
  • -15.28

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.08
  • 0.36
  • -28.77

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 30.93
  • 31.92
  • 34.43

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.81
  • 6.11
  • 6.05

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.43
  • 19.44
  • 20.64

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
99.76
73.89
35.01%
87.95
71.94
22.25%
80.18
67.72
18.40%
71.04
65.25
8.87%
Expenses
83.94
60.92
37.79%
74.08
62.12
19.25%
66.21
58.57
13.04%
61.18
63.11
-3.06%
EBITDA
15.82
12.97
21.97%
13.87
9.81
41.39%
13.97
9.15
52.68%
9.86
2.14
360.75%
EBIDTM
15.86%
17.56%
15.77%
13.64%
17.42%
13.51%
13.88%
3.29%
Other Income
3.68
2.10
75.24%
3.68
0.69
433.33%
3.22
0.47
585.11%
3.32
2.50
32.80%
Interest
0.49
0.34
44.12%
0.28
0.26
7.69%
0.36
0.12
200.00%
0.24
0.50
-52.00%
Depreciation
2.92
2.68
8.96%
2.94
1.23
139.02%
2.89
3.25
-11.08%
2.86
3.60
-20.56%
PBT
16.09
12.05
33.53%
14.33
9.01
59.05%
13.94
6.25
123.04%
10.08
0.54
1,766.67%
Tax
3.77
2.73
38.10%
4.29
2.53
69.57%
3.46
1.59
117.61%
1.58
0.02
7,800.00%
PAT
12.32
9.32
32.19%
10.03
6.49
54.55%
10.48
4.67
124.41%
8.51
0.52
1,536.54%
PATM
12.35%
12.62%
11.41%
9.02%
13.07%
6.89%
11.97%
0.80%
EPS
19.95
15.09
32.21%
16.24
10.50
54.67%
16.96
7.56
124.34%
13.77
0.84
1,539.29%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
338.93
278.08
317.50
257.97
151.69
153.17
Net Sales Growth
21.57%
-12.42%
23.08%
70.06%
-0.97%
 
Cost Of Goods Sold
158.69
140.32
146.99
102.34
64.36
62.63
Gross Profit
180.24
137.76
170.51
155.63
87.32
90.54
GP Margin
53.18%
49.54%
53.70%
60.33%
57.56%
59.11%
Total Expenditure
285.41
243.12
249.31
177.87
131.93
120.88
Power & Fuel Cost
-
18.53
16.29
10.15
10.30
9.02
% Of Sales
-
6.66%
5.13%
3.93%
6.79%
5.89%
Employee Cost
-
36.87
34.85
28.09
24.04
21.16
% Of Sales
-
13.26%
10.98%
10.89%
15.85%
13.81%
Manufacturing Exp.
-
24.14
28.94
18.22
17.22
13.21
% Of Sales
-
8.68%
9.11%
7.06%
11.35%
8.62%
General & Admin Exp.
-
8.79
6.23
5.11
6.11
5.33
% Of Sales
-
3.16%
1.96%
1.98%
4.03%
3.48%
Selling & Distn. Exp.
-
8.23
11.28
7.33
4.64
4.58
% Of Sales
-
2.96%
3.55%
2.84%
3.06%
2.99%
Miscellaneous Exp.
-
6.25
4.72
6.61
5.25
4.95
% Of Sales
-
2.25%
1.49%
2.56%
3.46%
3.23%
EBITDA
53.52
34.96
68.19
80.10
19.76
32.29
EBITDA Margin
15.79%
12.57%
21.48%
31.05%
13.03%
21.08%
Other Income
13.90
5.53
10.68
8.02
3.05
4.12
Interest
1.37
1.83
1.91
2.20
2.63
2.55
Depreciation
11.61
11.29
10.37
8.33
8.11
6.30
PBT
54.44
27.36
66.60
77.59
12.07
27.57
Tax
13.10
6.87
16.70
20.87
3.74
7.44
Tax Rate
24.06%
25.11%
25.08%
26.90%
30.99%
26.99%
PAT
41.34
20.50
49.90
56.72
8.34
20.13
PAT before Minority Interest
41.34
20.50
49.90
56.72
8.34
20.13
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
12.20%
7.37%
15.72%
21.99%
5.50%
13.14%
PAT Growth
96.86%
-58.92%
-12.02%
580.10%
-58.57%
 
EPS
66.68
33.06
80.48
91.48
13.45
32.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
222.55
203.22
154.46
98.96
92.12
Share Capital
3.09
3.09
3.09
3.09
3.09
Total Reserves
219.46
200.13
151.37
95.87
89.03
Non-Current Liabilities
6.24
8.06
11.16
11.62
11.90
Secured Loans
2.07
3.44
6.13
8.32
8.01
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.70
2.55
2.46
2.11
1.40
Current Liabilities
58.29
65.65
41.77
48.71
45.18
Trade Payables
24.59
37.16
29.53
20.83
16.12
Other Current Liabilities
3.67
4.44
6.12
6.34
5.61
Short Term Borrowings
28.41
23.43
4.83
14.60
15.31
Short Term Provisions
1.63
0.63
1.28
6.93
8.15
Total Liabilities
287.08
276.93
207.39
159.29
149.20
Net Block
87.91
88.77
64.13
67.74
60.94
Gross Block
139.39
129.53
95.96
91.81
74.07
Accumulated Depreciation
51.48
40.76
31.83
24.07
13.13
Non Current Assets
124.42
103.44
82.86
72.76
62.80
Capital Work in Progress
26.31
6.43
12.35
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
5.81
5.66
6.38
5.00
1.81
Other Non Current Assets
4.39
2.57
0.00
0.01
0.04
Current Assets
162.66
173.49
124.53
86.53
86.41
Current Investments
39.46
28.72
29.07
10.65
8.69
Inventories
26.99
56.01
37.85
27.90
18.61
Sundry Debtors
65.87
63.98
37.56
26.19
33.12
Cash & Bank
13.04
0.83
4.78
3.16
3.14
Other Current Assets
17.29
2.79
1.30
6.46
22.85
Short Term Loans & Adv.
14.86
21.17
13.97
12.17
15.61
Net Current Assets
104.36
107.84
82.76
37.82
41.23
Total Assets
287.08
276.93
207.39
159.29
149.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
35.29
13.82
27.35
20.46
8.85
PBT
27.36
66.60
77.59
12.07
27.57
Adjustment
11.53
11.33
4.73
12.16
7.87
Changes in Working Capital
3.26
-47.40
-34.09
-0.03
-19.15
Cash after chg. in Working capital
42.15
30.52
48.22
24.20
16.29
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.87
-16.70
-20.87
-3.74
-7.44
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-27.02
-14.20
-24.57
-20.85
-9.54
Net Fixed Assets
-28.15
-12.77
-4.41
-7.18
Net Investments
-10.74
0.35
-18.42
-5.69
Others
11.87
-1.78
-1.74
-7.98
Cash from Financing Activity
-1.08
-1.08
-1.08
0.00
0.00
Net Cash Inflow / Outflow
7.18
-1.46
1.70
-0.39
-0.70
Opening Cash & Equivalents
0.64
2.10
0.40
0.79
1.49
Closing Cash & Equivalent
7.83
0.64
2.10
0.40
0.79

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
360.23
328.94
250.01
160.18
149.11
ROA
7.27%
20.61%
31.42%
5.40%
13.49%
ROE
9.63%
27.90%
44.76%
8.72%
21.85%
ROCE
11.96%
33.91%
53.53%
11.93%
25.25%
Fixed Asset Turnover
2.07
2.82
2.75
1.83
2.07
Receivable days
85.22
58.36
45.10
71.37
78.93
Inventory Days
54.47
53.95
46.51
55.95
44.35
Payable days
71.92
72.38
78.66
47.96
48.15
Cash Conversion Cycle
67.77
39.93
12.95
79.36
75.13
Total Debt/Equity
0.15
0.15
0.11
0.29
0.29
Interest Cover
15.92
35.81
36.21
5.60
11.82

Top Investors:

News Update:


  • NGL Fine-Chem - Quarterly Results
    21st May 2024, 20:08 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.